🕵️ Immix Biopharma, Inc. ($IMMX)
SEC insider & ownership activity, last 12 months · CIK 1873835 · every row links its SEC filing
Over the last 12 months insiders bought $20K with no open-market selling against it. Gabriel S. Morris bought $10K in discretionary trades (Sep–Dec). Janus Henderson Group PLC added 9.1% → 13.0%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $20K (4 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Gabriel S. Morris | 2 | $10K | 0 | – | Dec 10, 2025 |
| Ilya M. Rachman | 2 | $10K | 0 | – | Dec 10, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 13.0% | 13G | Jun 5, 2026 | filing ↗ | |
| Saturn V Capital Management LP | 7.0% | 13G | Feb 17, 2026 | filing ↗ | |
| Xiaoying Tian | 7.0% | 13G | Feb 17, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jul 20, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 22, 2026 | filing ↗ |
| Other events (8.01) | May 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 21, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 21, 2026 | filing ↗ |
| Other events (8.01) | May 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 21, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 30, 2026 | filing ↗ |
| Other events (8.01) | Mar 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 25, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 7, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 7, 2025 | filing ↗ |
| Other events (8.01) | Dec 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 7, 2025 | filing ↗ |
| Other events (8.01) | Nov 26, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 26, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 5, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Sep 5, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 5, 2025 | filing ↗ |